Fujita Health University was selected for the "Program for Forming Japan’s Peak Research Universities (J-PEAKS)" in fiscal year 2024 and, as part of it, established the "Fujita Mind-BRIDGe" (Fujita Mind-Brain Research & Innovation Center for Drug Generation). Under this initiative, we are building a platform that promotes academia-driven drug discovery. This effort involves deepening collaborations with our partner institutions—including Hamamatsu University School of Medicine, the National Institute for Physiological Sciences, and Gifu Pharmaceutical University—as well as with other J-PEAKS universities and industry.
 

By integrating data science and insights from a broad range of disciplines, we aim to create a seamless pathway from basic research to clinical application, with a focus on drug discovery. Through these efforts, we seek to accelerate the translation of research findings into benefits for society and establish a world-leading international research hub.
 

As Fujita Mind-BRIDGe enters its second year, we are pleased to announce that the "Fujita International Symposium on Psychiatric and Neurological Disorders 2026" will be held on Saturday, November 14, 2026, at the Nagoya Marriott Associa Hotel. Under this year's theme, "Elucidating the Pathophysiology of Psychiatric and Neurological Disorders and Developing Therapeutic Interventions," we will invite speakers from Japan and abroad who are leaders in the fields of neuroscience and AI-driven drug discovery.